Technical Analysis for CLVLY - Clinuvel Pharm ADR

Grade Last Price % Change Price Change
grade A 21.91 -4.74% -1.0900
CLVLY closed down 4.74 percent on Thursday, October 17, 2019, on 82 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical CLVLY trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Down Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.74%
Calm After Storm Range Contraction -4.74%
Narrow Range Bar Range Contraction -4.74%
NR7 Range Contraction -4.74%
Inside Day Range Contraction -4.74%

Older signals for CLVLY ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Clinuvel Pharmaceuticals Limited is a biopharmaceutical company. The Company is focused on developing drugs for the treatment of a range of severe skin disorders. Its lead compound, SCENESSE (afamelanotide 16 milligrams), prevents phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company focuses at preventing the symptoms of skin diseases related to the exposure to harmful ultra violet (UV) radiation and at repigmentation of the skin due to a number of depigmentation disorders. SCENESSE has completed Phase II and III trials in the United States and Europe, and has been granted marketing authorization by the European Commission for adults with EPP. It has operations in Europe, the United States and Singapore. SCENESSE acts by increasing the levels of melanin in the skin and shields against UV radiation (UVR) and sunlight. SCENESSE is delivered via a subcutaneous dissolving implant.
Branches Of Biology Biopharmaceutical United States Organ Systems Radiation Burns Skin Diseases Ultraviolet Peptides Severe Skin Disorders Treatment Of A Range Of Severe Skin Disorders
Is CLVLY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 27.8
52 Week Low 10.6
Average Volume 14,601
200-Day Moving Average 19.086
50-Day Moving Average 18.5524
20-Day Moving Average 19.6212
10-Day Moving Average 22.192
Average True Range 1.1557
ADX 28.95
+DI 52.6188
-DI 32.5778
Chandelier Exit (Long, 3 ATRs ) 24.3329
Chandelier Exit (Short, 3 ATRs ) 19.9871
Upper Bollinger Band 26.4153
Lower Bollinger Band 12.8271
Percent B (%b) 0.67
BandWidth 69.252645
MACD Line 1.4764
MACD Signal Line 1.0254
MACD Histogram 0.451
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.3825
Resistance 3 (R3) 22.4017 22.2633 22.3038
Resistance 2 (R2) 22.2633 22.1430 22.2538 22.2775
Resistance 1 (R1) 22.0867 22.0687 22.0175 22.0675 22.2512
Pivot Point 21.9483 21.9483 21.9138 21.9388 21.9483
Support 1 (S1) 21.7717 21.8280 21.7025 21.7525 21.5688
Support 2 (S2) 21.6333 21.7537 21.6238 21.5425
Support 3 (S3) 21.4567 21.6333 21.5163
Support 4 (S4) 21.4375